Burden of blindness and visual impairment associated with corneal opacities in India.

IF 3.5 2区 医学 Q1 OPHTHALMOLOGY British Journal of Ophthalmology Pub Date : 2025-06-23 DOI:10.1136/bjo-2024-325763
Vivek Gupta, Praveen Vashist, Sukumara Sarath, Noopur Gupta, Suraj Singh Senjam, Palllavi Shukla, Bindiganavale Ramaswamy Shamanna, Vemparala Rajshekhar, Meenakshi Wadhwani, Amit Bhardwaj, Promila Gupta, Jeewan S Titiyal
{"title":"Burden of blindness and visual impairment associated with corneal opacities in India.","authors":"Vivek Gupta, Praveen Vashist, Sukumara Sarath, Noopur Gupta, Suraj Singh Senjam, Palllavi Shukla, Bindiganavale Ramaswamy Shamanna, Vemparala Rajshekhar, Meenakshi Wadhwani, Amit Bhardwaj, Promila Gupta, Jeewan S Titiyal","doi":"10.1136/bjo-2024-325763","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To obtain national-level data on current burden of blindness and visual impairment (VI) due to corneal opacities (CO) and their epidemiological determinants in India.</p><p><strong>Methods: </strong>A cross-sectional, population-based survey was conducted in 31 districts for population aged ≥50 years using Rapid Assessment of Avoidable Blindness (RAAB) V.6 methodology and 6 districts for population aged 0-49 years. Using standardised definitions, prevalence (95% CIs) and burden for 2023 were estimated at International Classification of Diseases-11 thresholds of mild/early VI (EVI) and moderate to severe VI (MSVI) and blindness.</p><p><strong>Results: </strong>85 135 participants aged ≥50 years and 13 695 participants between 0 and 49 years were examined. Prevalence of avoidable blindness due to CO was 17.1 per 10 000 (13.4 to 21.9) and 3.39 per 10 000 (1.16 to 9.92) in populations aged ≥50 years and 0-49 years, respectively. 32% (n=49) in ≥50-year group did not have perception of light in CO-affected eye. Prevalence of cumulative avoidable MSVI or blindness due to CO was 26.9/10 000 (20.7 to 35.0) and 8.32/10 000 (2.81 to 24.62) in populations aged ≥50 years and 0-49 years, respectively, while cumulative avoidable EVI, MSVI or blindness due to CO were 30.1/10 000 (23.8 to 38.1) and 8.3/10 000 (2.81 to 24.62), respectively.Higher prevalence of avoidable MSVI or blindness due to CO were associated with increasing age, lower educational status; lower prevalence was noted in northeast geographical zone. Rural-urban and gender-based differences were not statistically and clinically significant respectively.</p><p><strong>Conclusion: </strong>There is a high burden of CO-related blindness and VI in India, especially in older populations. Key epidemiological risks may be used for prioritisation in eye health plans.</p>","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":" ","pages":"829-836"},"PeriodicalIF":3.5000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bjo-2024-325763","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To obtain national-level data on current burden of blindness and visual impairment (VI) due to corneal opacities (CO) and their epidemiological determinants in India.

Methods: A cross-sectional, population-based survey was conducted in 31 districts for population aged ≥50 years using Rapid Assessment of Avoidable Blindness (RAAB) V.6 methodology and 6 districts for population aged 0-49 years. Using standardised definitions, prevalence (95% CIs) and burden for 2023 were estimated at International Classification of Diseases-11 thresholds of mild/early VI (EVI) and moderate to severe VI (MSVI) and blindness.

Results: 85 135 participants aged ≥50 years and 13 695 participants between 0 and 49 years were examined. Prevalence of avoidable blindness due to CO was 17.1 per 10 000 (13.4 to 21.9) and 3.39 per 10 000 (1.16 to 9.92) in populations aged ≥50 years and 0-49 years, respectively. 32% (n=49) in ≥50-year group did not have perception of light in CO-affected eye. Prevalence of cumulative avoidable MSVI or blindness due to CO was 26.9/10 000 (20.7 to 35.0) and 8.32/10 000 (2.81 to 24.62) in populations aged ≥50 years and 0-49 years, respectively, while cumulative avoidable EVI, MSVI or blindness due to CO were 30.1/10 000 (23.8 to 38.1) and 8.3/10 000 (2.81 to 24.62), respectively.Higher prevalence of avoidable MSVI or blindness due to CO were associated with increasing age, lower educational status; lower prevalence was noted in northeast geographical zone. Rural-urban and gender-based differences were not statistically and clinically significant respectively.

Conclusion: There is a high burden of CO-related blindness and VI in India, especially in older populations. Key epidemiological risks may be used for prioritisation in eye health plans.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度与角膜混浊相关的失明和视力损害负担。
目的:获取印度目前由角膜混浊(CO)引起的失明和视力损害(VI)负担及其流行病学决定因素的国家级数据。方法:采用可避免失明快速评估(RAAB) V.6方法对31个地区≥50岁人群和6个地区0-49岁人群进行横断面调查。使用标准化定义,根据国际疾病分类-11轻度/早期VI (EVI)和中度至重度VI (MSVI)和失明的阈值估计2023年的患病率(95% ci)和负担。结果:共纳入85 135名年龄≥50岁的参与者和13 695名年龄在0 ~ 49岁之间的参与者。在≥50岁和0-49岁人群中,可避免的一氧化碳致盲患病率分别为17.1 / 10 000(13.4 ~ 21.9)和3.39 / 10 000(1.16 ~ 9.92)。≥50岁组中32% (n=49)的患者患眼无光觉。≥50岁和0 ~ 49岁人群累积可避免的CO致MSVI或致盲患病率分别为26.9/ 10000(20.7 ~ 35.0)和8.32/ 10000(2.81 ~ 24.62),累积可避免的EVI和CO致MSVI或致盲患病率分别为30.1/ 10000(23.8 ~ 38.1)和8.3/ 10000(2.81 ~ 24.62)。可避免的MSVI或CO致盲的高患病率与年龄增加、受教育程度低有关;东北地区患病率较低。城乡差异和性别差异均无统计学意义和临床意义。结论:在印度,co相关性失明和VI的负担很高,特别是在老年人群中。关键的流行病学风险可用于眼科保健计划的优先次序。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.30
自引率
2.40%
发文量
213
审稿时长
3-6 weeks
期刊介绍: The British Journal of Ophthalmology (BJO) is an international peer-reviewed journal for ophthalmologists and visual science specialists. BJO publishes clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. It also provides major reviews and also publishes manuscripts covering regional issues in a global context.
期刊最新文献
Aqueous humour outflow improvement after excimer laser trabeculostomy. The Manchester buckle study: 15-year outcomes and predictive factors for success in scleral buckling for primary rhegmatogenous retinal detachment. Long-term outcomes of and a risk score model for moderate-risk to high-risk penetrating keratoplasty. Trends in follow-up visits and visual acuity gain in infectious keratitis: report from a tertiary eye care centre. Biomarker changes of choroidal architecture preceding myopia onset in Chinese school children: a 3-year prospective cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1